Sinopharm Group Co (HKSE:01099) Forward PE Ratio : 6.14 (As of Apr. 29, 2024)

View and export this data going back to 2009. Start your Free Trial

What is Sinopharm Group Co Forward PE Ratio?

Sinopharm Group Co's Forward PE Ratio for today is 6.14.

Sinopharm Group Co's PE Ratio without NRI for today is 5.35.

Sinopharm Group Co's PE Ratio for today is 6.56.

Sinopharm Group Co Forward PE Ratio Historical Data

The historical data trend for Sinopharm Group Co's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Group Co Forward PE Ratio Chart

Sinopharm Group Co Annual Data

Trend

2018-12

2019-12

2020-12

2021-12

2022-12

2023-12

2024-04

Forward PE Ratio

12.63

10.65

7.33

7.27

6.78

5.10

6.56

Sinopharm Group Co Quarterly Data
	2018-03	2018-06	2018-09	2018-12	2019-03	2019-06	2019-09	2019-12	2020-03	2020-06	2020-09	2020-12	2021-03	2021-06	2021-09	2021-12	2022-03	2022-06	2022-09	2022-12	2023-03	2023-06	2023-09	2023-12	2024-03
Forward PE Ratio	14.35	15.58	17.24	12.63	13.62	11.95	9.80	10.65	7.14	8.92	6.82	7.33	6.76	8.16	8.45	7.27	7.75	8.77	5.92	6.78	7.51	8.15	6.14	5.10	8.08

Competitive Comparison of Sinopharm Group Co's Forward PE Ratio

For the Medical Distribution subindustry, Sinopharm Group Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinopharm Group Co's Forward PE Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sinopharm Group Co's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Sinopharm Group Co's Forward PE Ratio falls into.

Sinopharm Group Co Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Sinopharm Group Co (HKSE:01099) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .

Sinopharm Group Co Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Sinopharm Group Co's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinopharm Group Co (HKSE:01099) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinopharm Group Co Ltd (HKSE:01099) » Definitions » Forward PE Ratio

Comparable Companies

Traded in Other Exchanges

SHTDY:USA SHTDF:USA X2S:Germany X2S:Germany

Address

No. 385, East Longhua Road, Sinopharm Group Building, Huangpu District, Shanghai, CHN, 200023

Website

http://www.sinopharmgroup.com.cn

Sinopharm Group was founded in 2003 and listed on the Hong Kong Stock Exchange in September 2009. Its main business is drug distribution in mainland China, which contributes about 75% of total revenue. It is the largest drug distributor, with approximately 20% market share. Other notable segments are medical device distribution, which contributes about 20% of revenue, and retail pharmacies, which contributes about 5%. These are fast-growing industries, where government policy is designed to encourage consolidation and promote large players with scale and efficiency advantages.

Sinopharm Group Co (HKSE:01099) Headlines

No Headlines